Key highlights from Eli Lilly’s (LLY) Q2 2025 earnings results
Eli Lilly and Company (NYSE: LLY) reported its second quarter 2025 earnings results today. Worldwide revenue was $15.56 billion, up 38% from the same period a year ago. GAAP net income increased 91% to $5.6 billion, or $6.29 per share, compared to last year. Adjusted EPS rose 61% to $6.31. The company raised its full-year … Read more